BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32747660)

  • 1. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors.
    Vougiouklakis T; Aung PP; Vasudevaraja V; Prieto VG; Torres-Cabala CA; Sulman EP; Snuderl M; Jour G
    Sci Rep; 2020 Aug; 10(1):12996. PubMed ID: 32747660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor.
    Jour G; Vasudevaraja V; Prieto VG; Snuderl M; Torres-Cabala CA; Al-Rohil R; Sulman EP; Ballester LY; Aung PP
    Mod Pathol; 2019 Mar; 32(3):338-345. PubMed ID: 30310175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
    Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
    Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
    Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
    Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors.
    Feber A; Wilson GA; Zhang L; Presneau N; Idowu B; Down TA; Rakyan VK; Noon LA; Lloyd AC; Stupka E; Schiza V; Teschendorff AE; Schroth GP; Flanagan A; Beck S
    Genome Res; 2011 Apr; 21(4):515-24. PubMed ID: 21324880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor‒Like Melanoma.
    Muniz TP; Sorotsky H; Kanjanapan Y; Rose AAN; Araujo DV; Fortuna A; Ghazarian D; Kamil ZS; Pugh T; Mah M; Thiagarajah M; Torti D; Spreafico A; Hogg D
    J Invest Dermatol; 2021 Oct; 141(10):2470-2479. PubMed ID: 33831431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas.
    Jour G; Andeen NK; Al-Rohil R; Aung PP; Mehrotra M; Duose D; Hoch B; Argenyi Z; Luthra R; Wistuba II; Prieto VG
    J Pathol; 2018 Jan; 244(1):97-106. PubMed ID: 28991373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve sheath tumors from patients with neurofibromatosis type 1 do not have the chromosomal translocation t(X;18).
    Liew MA; Coffin CM; Fletcher JA; Hang MT; Tanito K; Niimura M; Viskochil D
    Pediatr Dev Pathol; 2002; 5(2):165-9. PubMed ID: 11910511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells.
    Hölzel M; Landsberg J; Glodde N; Bald T; Rogava M; Riesenberg S; Becker A; Jönsson G; Tüting T
    Cancer Res; 2016 Jan; 76(2):251-63. PubMed ID: 26511633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
    Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
    Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
    Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
    J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.